The National Institutes of Health (NIH) has awarded McLean Hospital’s Neuroregeneration Institute (NRI) a $6 million grant over 5 years to further its groundbreaking research on stem cell-based therapy for Parkinson’s disease (PD). The NIH developed the Cooperative Research to Enable and Advance...
Drs. Ole Isacson and Penny Hallett find a likely early indicator for Parkinson’s disease.
A team of researchers including Drs. Ole Isacson and Penny Hallett has found that elevated levels of certain types of fat molecules in the brain may be an early sign of Parkinson’s disease.
A collaborative team of researchers at McLean Hospital, a Harvard Medical School affiliate, and the University of Oxford has found that elevated levels of certain types of lipids (fat molecules) in the brain may be an early sign of Parkinson’s disease (PD). This finding could have significant...
Penny Hallett, PhD, is an assistant professor of psychiatry at Harvard Medical School and co-director of the Neuroregeneration Research Institute (NRI). She received her PhD from the University of Manchester, UK, and completed post-doctoral studies at Massachusetts General Hospital, moving in 2006...
